MBMadan Lal Brahma Bhatt

Madan Lal Brahma Bhatt

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Madan Lal Brahma Bhatt has a total of 17 co-authors. Here are the top co-authors by number of shared publications:

  • Anupam Mishra

    Department of Otorhinolaryngology & Head Neck Surgery King George’s Medical University Lucknow India

    3 shared publications
  • Parul Dubey

    Department of Radiotherapy King George’s Medical University Lucknow India

    3 shared publications
  • Rajeev Gupta

    Department of Radiotherapy King George’s Medical University Lucknow India

    3 shared publications
  • Vijay Kumar

    Department of Surgical Oncology King George’s Medical University Lucknow India

    3 shared publications
  • Smrati Bhadauria

    Division of Toxicology & Experimental Medicine Central Drug Research Institute (CSIR) Lucknow India

    2 shared publications
  • Deep Chakrabarti

    Genitourinary Oncology, The Royal Marsden NHS Foundation Trust, London, United Kingdom

    1 shared publication

Latest Publications

  • Open Access

    Evaluation of correlation between CD44, radiotherapy response, and survival rate in patients with advanced stage of head and neck squamous cell carcinoma (HNSCC)

    by Parul Dubey, Rajeev Gupta, Anupam Mishra, Vijay Kumar, Smrati Bhadauria, Madan Lal Brahma Bhatt

    Purpose: Cancer stem cells (CSCs) constitute a distinctive subpopulation of cancer cells that are competent in tumor initiation, invasion, recurrence, and resistance to chemoradiotherapy. CD44, a hyaluronic acid (HA) receptor has been considered as a potential CSC marker in head and neck cancer. The purpose of this study is to evaluate the correlation between CD44 and clinicopathological parameters, treatment response, survival, and recurrence.Methods: The CD44 expression was examined by immunohistochemistry (IHC) in 90 samples of head and neck squamous cell carcinoma (HNSCC) confirmed patients. The expression of CD44 and its association with clinicopathological parameters, treatment response, and survival was determined.Results: In all HNSCC patient samples, CD44 was expressed consistently at different intensities. Tumor size (p < 0.001), stage (p < 0.001), and treatment response (p < 0.001) showed statistically significant association with CD44 expression. Alcohol and CD44 were observed as independent predictors of response to radiotherapy using multivariate ordinal logistic regression analysis. Analysis of 2‐year overall survival (OS) showed that CD44 expression (p = 0.02), tumor size (p = 0.001), lymph node status (p < 0.001), stage (p < 0.001), and grade (p = 0.007) were significantly associated with OS. Using Cox regression analysis, lymph node status (p = 0.001), grade (p < 0.001), recurrence (p < 0.001), and CD44 expression (p = 0.003) were found to be potential independent predictors of OS.Conclusion: Our findings suggest that CD44 contributes to resistance to radiotherapy and poor OS. The results also suggest that except for CD44 there could be other factors such as lymph node metastasis, grade, and alcohol which should be investigated as potential targets for therapy.


  • Open Access

    Association of ALDH1 with Response to Radiotherapy and Its Impact on Survival in Patients with Advanced Stage of Head and Neck Squamous Cell Carcinoma (HNSCC)

    by Parul Dubey, Narayan Kumar, Rajeev Gupta, Anupam Mishra, Smrati Bhadauriya, Vijay Kumar, Madanlal Brahma Bhatt

    Background: The presence of cancer stem-like cells within tumor microenvironment distinctly governs response to chemo-radiotherapy. The ALDH1 (Aldehyde dehydrogenase 1) has emerged as a cancer stem cell (CSC) marker in various tumors. The aim of the study was to examine the expression of ALDH1 in HNSCC patients undergoing radiotherapy to evaluate its correlation with clinicopathological parameter, treatment response and survival. Methods: Expression of ALDH1 was evaluated by immunohistochemistry in 90 histopathologically confirmed HNSCC patients and 90 matched controls. The association between ALDH1 expression, clinicopathological parameters and treatment response was determined. Results: The immunohistochemistry results showed that ALDH1 was consistently expressed in all the HNSCC specimens although at different intensities. On the other hand, control specimens did not show similar expression of ALDH1. ALDH1 expression demonstrated statistically significant association with tumor size (p<0.001), lymph node status (p<0.001), stage (p<0.001), grade (p<0.001) and treatment response (p<0.001). Multivariate ordinal logistic regression analysis indicated alcohol and ALDH1 as an independent predictor of responsiveness to radiotherapy in HNSCC patients. Multivariate Cox regression analysis indicated that lymph node status (p=0.020), grade (p=0.006) and recurrence (p=0.002) were potential independent predictors of overall survival. Conclusion: From previous studies, ALDH1 has been contemplated not only as a promising prognostic and diagnostic marker but also as a likely drug target. Our study gives new understanding regarding the association between ALDH1, cancer prognosis and radioresistance. Our findings suggest that ALDH1, lymph node status, grade and alcohol could be the viable targets for HNSCC and it also provides new prospects for radiotherapy sensitivity in HNSCC.


  • Open Access

    Evaluation of Correlation between CD44, Radiotherapy Response and Survival Rate in Patients with Advanced Stage of Head and Neck Squamous Cell Carcinoma (HNSCC)

    by Parul Dubey, Rajeev Gupta, Anupam Mishra, Vijay Kumar, Smrati Bhadauria, Madan Lal Brahma Bhatt

    Purpose Cancer stem cells (CSCs) constitute a distinctive subpopulation of cancer cells that are competent in tumor initiation, invasion, recurrence, and resistance to chemo-radiotherapy. CD44, a hyaluronic acid (HA) receptor has been considered as a potential CSC marker in head and neck cancer. The purpose of this study is to evaluate the correlation between CD44 and clinicopathological parameters, treatment response, survival, and recurrence. Methods CD44 expression was examined by immunohistochemistry (IHC) in 90 samples of head and neck squamous cell carcinoma (HNSCC) confirmed patients. Expression of CD44 and its association with clinicopathological parameters, treatment response, and survival was determined. Results In all HNSCC patient samples, CD44 was expressed consistently at different intensities. Tumor size (pConclusion Our findings suggest that CD44 contributes to resistance to radiotherapy and poor OS. The results also suggest that except for CD44 there could be other factors such as lymph node metastasis, grade, and alcohol which should be investigated as potential targets for therapy.

  • Open Access

    Therapeutic Development and Drugs for the Treatment of COVID-19

    by Vimal K. Maurya, Swatantra Kumar, Madan L. B. Bhatt, Shailendra K. Saxena

    SARS-CoV-2/novel coronavirus (2019-nCoV) is a new strain that has recently been confirmed in Wuhan City, Hubei Province of China, and spreads to more than 165 countries of the world including India. The virus infection leads to 245,922 confirmed cases and 10,048 deaths worldwide as of March 20, 2020. Coronaviruses (CoVs) are lethal zoonotic viruses, highly pathogenic in nature, and responsible for diseases ranging from common cold to severe illness such as Middle East respiratory syndrome (MERS) and severe acute respiratory syndrome (SARS) in humans for the past 15 years. Considering the severity of the current and previous outbreaks, no approved antiviral agent or effective vaccines are present for the prevention and treatment of infection during the epidemics. Although, various molecules have been shown to be effective against coronaviruses both in vitro and in vivo, but the antiviral activities of these molecules are not well established in humans. Therefore, this chapter is planned to provide information about available treatment and preventive measures for the coronavirus infections during outbreaks. This chapter also discusses the possible role of supportive therapy, repurposing drugs, and complementary and alternative medicines for the management of coronaviruses including COVID-19.


  • Open Access

    Long-course chemoradiation in carcinoma rectum; is it really worth it? Perspectives from a developing nation

    by D. Chakrabarti, S. Rajan, N. Akhtar, V. Kumar, R. Kumar, K. Srivastava, M. Bhatt, R. Gupta

    Introduction: Colorectal cancer is the third most common cancer worldwide by incidence, and second most common cause of cancer-associated mortality. Total mesorectal excision (TME) with negative margins including a negative CRM is the primary goal to avoid locoregional recurrences and improve survival in carcinoma rectum. Tumour excision may not always be possible in treating locally advanced disease and the likelihood of R1-2 resection is high. Primary aim of preoperative long-course chemoradiation is tumour shrinkage and improving R0 resection rate. However, the optimal fractionation in relation to radiotherapy is still controversial.